Cargando…
FTO Polymorphisms are Associated with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Susceptibility in the Older Chinese Han Population
BACKGROUND: As fat and obesity play a vital role in the pathophysiology of metabolic dysfunction-associated fatty liver disease (MAFLD), this study aims to investigate the association between the fat mass and obesity-associated gene (FTO) and MAFLD. METHODS: Six SNPs (rs6499640, rs1421085, rs8050136...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429205/ https://www.ncbi.nlm.nih.gov/pubmed/32848374 http://dx.doi.org/10.2147/CIA.S254740 |
_version_ | 1783571241278373888 |
---|---|
author | Gu, Zhan Bi, Yan Yuan, Fan Wang, Ruirui Li, Dong Wang, Jianying Hu, Xiaojuan He, Guang Zhang, Lei Liu, Bao-cheng |
author_facet | Gu, Zhan Bi, Yan Yuan, Fan Wang, Ruirui Li, Dong Wang, Jianying Hu, Xiaojuan He, Guang Zhang, Lei Liu, Bao-cheng |
author_sort | Gu, Zhan |
collection | PubMed |
description | BACKGROUND: As fat and obesity play a vital role in the pathophysiology of metabolic dysfunction-associated fatty liver disease (MAFLD), this study aims to investigate the association between the fat mass and obesity-associated gene (FTO) and MAFLD. METHODS: Six SNPs (rs6499640, rs1421085, rs8050136, rs3751812, rs9939609 and rs9930506) within FTO were genotyped for 741 MAFLD patients (median age, 69.98; interquartile range, 66.55–75.93) and 825 healthy people (median age, 69.94; interquartile range, 66.39–75.64). Allele and genotype frequencies, pairwise linkage disequilibrium (LD) and haplotype analysis were calculated. RESULTS: BMI, waist circumference, systolic blood pressure, diastolic blood pressure, fasting plasma glucose, triglyceride, alanine transaminase, glutamyl transpeptidase and the prevalence of diabetes were found to be higher in the MAFLD individuals comparing to the control ones (P < 0.05). For rs1421085, the C allele frequency was remarkably higher in MAFLD after Bonferroni correction (OR [95% CI] =1.353 [1.095–1.671]; P(corr) =0.030), and a significantly different genotype result was observed in log-additive model (OR [95% CI] =1.369 [1.108–1.691]; P(corr) =0.024). For rs8050136, significantly increased A allele frequency was observed in MAFLD (OR [95% CI] =1.371 [1.109–1.695]; P(corr) =0.024), and A-allele carriers showed increased MAFLD risk (OR [95% CI] =1.393 [1.103–1.759]; P(corr) =0.030). For rs3751812, the T allele frequency was remarkably higher in MAFLD (OR [95% CI] =1.369 [1.108–1.691]; P(corr) =0.024), and T-allele carriers demonstrated high MAFLD risk (OR [95% CI] =1.392 [1.103–1.756]; P(corr) =0.030). For rs9939609, A allele frequency was also remarkably high in MAFLD (OR [95% CI] =1.369 [1.108–1.691]; P(corr) =0.024), and A-allele carriers were more susceptible to MAFLD (OR [95% CI] =[1.103–1.756]; P(corr) =0.030). A strong LD was found among rs1421085, rs8050136, rs3751812 and rs9939609 (r(2) >0.8), and individuals with C-A-T-A haplotype had an elevated MAFLD risk (P =0.005). CONCLUSION: The case-control study indicated that C variant of rs1421085, A variant of rs8050136, T variant of rs3751812 and A variant of rs9939609 are associated with elevated MAFLD risk in the older Chinese Han population. |
format | Online Article Text |
id | pubmed-7429205 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-74292052020-08-25 FTO Polymorphisms are Associated with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Susceptibility in the Older Chinese Han Population Gu, Zhan Bi, Yan Yuan, Fan Wang, Ruirui Li, Dong Wang, Jianying Hu, Xiaojuan He, Guang Zhang, Lei Liu, Bao-cheng Clin Interv Aging Original Research BACKGROUND: As fat and obesity play a vital role in the pathophysiology of metabolic dysfunction-associated fatty liver disease (MAFLD), this study aims to investigate the association between the fat mass and obesity-associated gene (FTO) and MAFLD. METHODS: Six SNPs (rs6499640, rs1421085, rs8050136, rs3751812, rs9939609 and rs9930506) within FTO were genotyped for 741 MAFLD patients (median age, 69.98; interquartile range, 66.55–75.93) and 825 healthy people (median age, 69.94; interquartile range, 66.39–75.64). Allele and genotype frequencies, pairwise linkage disequilibrium (LD) and haplotype analysis were calculated. RESULTS: BMI, waist circumference, systolic blood pressure, diastolic blood pressure, fasting plasma glucose, triglyceride, alanine transaminase, glutamyl transpeptidase and the prevalence of diabetes were found to be higher in the MAFLD individuals comparing to the control ones (P < 0.05). For rs1421085, the C allele frequency was remarkably higher in MAFLD after Bonferroni correction (OR [95% CI] =1.353 [1.095–1.671]; P(corr) =0.030), and a significantly different genotype result was observed in log-additive model (OR [95% CI] =1.369 [1.108–1.691]; P(corr) =0.024). For rs8050136, significantly increased A allele frequency was observed in MAFLD (OR [95% CI] =1.371 [1.109–1.695]; P(corr) =0.024), and A-allele carriers showed increased MAFLD risk (OR [95% CI] =1.393 [1.103–1.759]; P(corr) =0.030). For rs3751812, the T allele frequency was remarkably higher in MAFLD (OR [95% CI] =1.369 [1.108–1.691]; P(corr) =0.024), and T-allele carriers demonstrated high MAFLD risk (OR [95% CI] =1.392 [1.103–1.756]; P(corr) =0.030). For rs9939609, A allele frequency was also remarkably high in MAFLD (OR [95% CI] =1.369 [1.108–1.691]; P(corr) =0.024), and A-allele carriers were more susceptible to MAFLD (OR [95% CI] =[1.103–1.756]; P(corr) =0.030). A strong LD was found among rs1421085, rs8050136, rs3751812 and rs9939609 (r(2) >0.8), and individuals with C-A-T-A haplotype had an elevated MAFLD risk (P =0.005). CONCLUSION: The case-control study indicated that C variant of rs1421085, A variant of rs8050136, T variant of rs3751812 and A variant of rs9939609 are associated with elevated MAFLD risk in the older Chinese Han population. Dove 2020-08-11 /pmc/articles/PMC7429205/ /pubmed/32848374 http://dx.doi.org/10.2147/CIA.S254740 Text en © 2020 Gu et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Gu, Zhan Bi, Yan Yuan, Fan Wang, Ruirui Li, Dong Wang, Jianying Hu, Xiaojuan He, Guang Zhang, Lei Liu, Bao-cheng FTO Polymorphisms are Associated with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Susceptibility in the Older Chinese Han Population |
title | FTO Polymorphisms are Associated with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Susceptibility in the Older Chinese Han Population |
title_full | FTO Polymorphisms are Associated with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Susceptibility in the Older Chinese Han Population |
title_fullStr | FTO Polymorphisms are Associated with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Susceptibility in the Older Chinese Han Population |
title_full_unstemmed | FTO Polymorphisms are Associated with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Susceptibility in the Older Chinese Han Population |
title_short | FTO Polymorphisms are Associated with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Susceptibility in the Older Chinese Han Population |
title_sort | fto polymorphisms are associated with metabolic dysfunction-associated fatty liver disease (mafld) susceptibility in the older chinese han population |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429205/ https://www.ncbi.nlm.nih.gov/pubmed/32848374 http://dx.doi.org/10.2147/CIA.S254740 |
work_keys_str_mv | AT guzhan ftopolymorphismsareassociatedwithmetabolicdysfunctionassociatedfattyliverdiseasemafldsusceptibilityintheolderchinesehanpopulation AT biyan ftopolymorphismsareassociatedwithmetabolicdysfunctionassociatedfattyliverdiseasemafldsusceptibilityintheolderchinesehanpopulation AT yuanfan ftopolymorphismsareassociatedwithmetabolicdysfunctionassociatedfattyliverdiseasemafldsusceptibilityintheolderchinesehanpopulation AT wangruirui ftopolymorphismsareassociatedwithmetabolicdysfunctionassociatedfattyliverdiseasemafldsusceptibilityintheolderchinesehanpopulation AT lidong ftopolymorphismsareassociatedwithmetabolicdysfunctionassociatedfattyliverdiseasemafldsusceptibilityintheolderchinesehanpopulation AT wangjianying ftopolymorphismsareassociatedwithmetabolicdysfunctionassociatedfattyliverdiseasemafldsusceptibilityintheolderchinesehanpopulation AT huxiaojuan ftopolymorphismsareassociatedwithmetabolicdysfunctionassociatedfattyliverdiseasemafldsusceptibilityintheolderchinesehanpopulation AT heguang ftopolymorphismsareassociatedwithmetabolicdysfunctionassociatedfattyliverdiseasemafldsusceptibilityintheolderchinesehanpopulation AT zhanglei ftopolymorphismsareassociatedwithmetabolicdysfunctionassociatedfattyliverdiseasemafldsusceptibilityintheolderchinesehanpopulation AT liubaocheng ftopolymorphismsareassociatedwithmetabolicdysfunctionassociatedfattyliverdiseasemafldsusceptibilityintheolderchinesehanpopulation |